Abivax (ABVX) Cash & Equivalents (2021 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Abivax (ABVX) has 2 years of Cash & Equivalents data on record, last reported at $27.5 million in Q4 2022.

• For Q4 2022, Cash & Equivalents fell 60.4% year-over-year to $27.5 million; the TTM value through Dec 2022 reached $27.5 million, down 60.4%, while the annual FY2023 figure was $272.5 million, 859.47% up from the prior year.
• Cash & Equivalents reached $27.5 million in Q4 2022 per ABVX's latest filing, down from $69.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $69.4 million in Q4 2021 and bottomed at $27.5 million in Q4 2022.

Peer Comparison